Guangzhou Baiyunshan Announces Vice Chair Resignation and Change of Authorised Representative

Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has provided an announcement.

Guangzhou Baiyunshan Pharmaceutical Holdings announced that vice chairperson and executive director Ms. Cheng Ning has resigned from all her positions, including as a member of the Budget Committee and as an authorised representative under Hong Kong listing rules, after reaching the statutory retirement age. The company stressed that her departure will not reduce the board below the legal minimum, will not affect normal board operations, and that she leaves with no disputes or outstanding obligations, having completed handover procedures, while the board expressed gratitude for her service.

Following Ms. Cheng’s resignation, she will no longer act as an authorised representative of the company, and company secretary Ms. Huang Xuezhen has been appointed to that role with effect from 6 March 2026. The board’s current composition remains compliant with governance requirements, signaling continuity in corporate oversight and regulatory liaison despite the leadership transition.

The most recent analyst rating on (HK:0874) stock is a Hold with a HK$20.00 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.

More about Guangzhou Baiyunshan Pharmaceutical Holdings Company

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a joint stock company incorporated in the People’s Republic of China and listed in Hong Kong. The group operates in the pharmaceutical industry, focusing on the manufacture and distribution of medicines and related healthcare products for domestic and international markets.

Average Trading Volume: 1,258,378

Technical Sentiment Signal: Buy

Current Market Cap: HK$43.72B

Find detailed analytics on 0874 stock on TipRanks’ Stock Analysis page.